cll: treatment pathway changes and cost effectiveness
Published 6 years ago • 105 plays • Length 3:52Download video MP4
Download video MP3
Similar videos
-
2:50
diagnostic factors and treatment changes in cll
-
4:58
how do payers assess value of treatments in cll?
-
0:58
what is cll, and does everyone really needs treatment? | dr. jeff sharman | oncology brothers #2023
-
2:28
utilizing the notch1 pathway in cll treatment
-
50:47
emerging treatments and evolving pathways for the management of chronic lymphocytic leukemia
-
25:38
cll: chemotherapy and ibrutinib based regimens
-
1:03:50
new frontiers and emerging treatments for cll
-
20:40
cll: treatment for btki progressors
-
1:08:25
cll treatment new options, more hope
-
24:09
update on venetoclax for cll
-
1:29:54
dr el sharkawi - cll treatment, now and in the future
-
50:25
the latest cll treatments and therapies with dr jan burger
-
1:44
ibrutinib and fcr in cll irrespective of ighv mutation status
-
3:26
the current status of cll treatment and how clinical practice will change
-
1:05
microenvironmental interactions and signaling pathways in cll
-
27:28
risk assessment in cll treatment
-
5:03
understanding patient perspectives in cll treatment
-
1:36
dr. davids on cost effectiveness of time-limited therapy with venetoclax/obinutuzumab in cll
-
27:18
novel treatment options in cll